ORIGINAL ARTICLE
Clinical and demographic profile of mild COVID-19 disease: The experience of a single center in India
Parikshit Thakare 1,   Sandeep Sharma 2,   Abhishek Gupta 1,   Sarika Patil 3,   Ketaki Utpat 2,   Unnati Desai 4  
,   Jyotsna Joshi 5,   Mohan Joshi 6
 
More details
Hide details
1
Senior Medical Officer, Department of Pulmonary Medicine, Mumbai
2
Assistant Professor, Department of Pulmonary Medicine, Mumbai
3
Nodal Officer for COVID, Mumbai
4
Associate Professor and Incharge, Department of Pulmonary Medicine, Mumbai
5
Former Professor and Head, Department of Pulmonary Medicine, Mumbai
6
TNMC and BYL Nair Hospital, Mumbai
CORRESPONDING AUTHOR
Unnati Desai   

Pulmonary Medicine, T. N. Medical College and B. Y. L. Nair Hospital, Mumbai 400008, India
Publication date: 2021-08-30
 
Pneumon 2020;33(4):187–190
 
KEYWORDS
ABSTRACT
Over the small period of time COVID-19 has become a global pandemic and affected hundreds of countries all over the world. The main objective of our study is to report clinical and demographic profile of mild cases of COVID-19 disease. It is a descriptive study of 105 COVID-19 positive patients whose diagnosis was confirmed with polymerase chain reaction (PCR). The clinical, radiological and laboratory data were collected including age, sex, contact history, symptoms, duration of stay and swab conversion rate. The mean age of population was 39.75 years with a male preponderance. The most common symptom noted was sore throat (29.52%) followed by fever (26.67%). The vital and laboratory parameters were normal in all. All patients recovered with no residual symptoms. We used the innovative 40 step test to early identity deterioration. Eight cases were transferred to high dependency unit/intensive care in view of breathlessness & desaturation in oxygen level and recovered completely. We had no deaths.
ACKNOWLEDGEMENTS
The TNMC COVID core committee and COVID task force.
CONFLICTS OF INTEREST
None.
 
REFERENCES (12)
1.
Antoniou K, Bolaki M, Bibaki E, et al. COVID19 alert Do we know our enemy? Pneumon 2020; 33:25-7.
 
2.
Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta bio-medica: Atenei Parmensis. 2020; 91:157-60.
 
3.
Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. New England journal of medicine 2020; 382:1708-20.
 
4.
Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. The Lancet 2020; 395:507-13.
 
5.
Gupta N, Agrawal S, Ish P, et al. Safdarjung Hospital COVID 2019 working group. Clinical and epidemiologic profile of the initial COVID-19 patients at a tertiary care centre in India. Monaldi Archives for Chest Disease 2020; 90. Available from https://doi.org/10.4081/monald....
 
6.
Karampitsakos T, Akinosoglou K, Papaioannou O, et al. Increased red cell distribution width is associated with disease severity in hospitalized adults with SARS-CoV-2 infection: An observational multicentric study. Front Med 7:616292. doi: 10.3389/ fmed.2020.616292.
 
7.
Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA 2020; 323:1061-9.
 
8.
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet 2020; 395(10223): 497-506.
 
9.
Zhang JJ, Dong X, Cao YY, et al. Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China. Allergy 2020; 75:1730-41.
 
10.
Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet 2020; 395:1054-62.
 
11.
Gautret P, Lagier JC, Parola P, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an openlabel non-randomized clinical trial. International journal of antimicrobial agents 2020; 105949. doi: 10.1016/j.ijantimicag.2020.105949.
 
12.
Greenhalgh T, Javid B, Knight M, Inada-Kim M on behalf of the Oxford COVID-19 Evidence Service Team. What is the efficacy and safety of rapid exercise tests for exertional desaturation in covid-19? Available from https://www.cebm.net/covid-19/..., Accessed on 3rd June 2020.
 
eISSN:1791-4914
ISSN:1105-848X